A Prospective Multi-Center Randomized Controlled Single Blind Clinical Trial Evaluating the Safety and Efficacy of the Cordella Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class III Heart Failure Patients (PROACTIVE-HF Trial)

Brief description of study

The main purpose of this research study is to reduce Heart Failure Hospitalizations. Endotronix, Inc. has begun a study of an investigational device (also known as the “study device”) called Cordella™ Pulmonary Artery Sensor System as a possible treatment for New York Heart Association (NYHA) Class III heart failure. An investigational device is one that has not been approved by the United States (US) Food and Drug Administration (FDA).

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.